Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

11.9%

8 terminated out of 67 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

28%

19 trials in Phase 3/4

Results Transparency

14%

5 of 36 completed with results

Key Signals

5 with results82% success

Data Visualizations

Phase Distribution

46Total
Not Applicable (20)
P 1 (1)
P 2 (6)
P 3 (9)
P 4 (10)

Trial Status

Completed36
Unknown13
Terminated8
Withdrawn4
Not Yet Recruiting3
Recruiting2

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 36 completed trials

Clinical Trials (67)

Showing 20 of 20 trials
NCT07163689Recruiting

TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease

NCT07012863Phase 4Not Yet Recruiting

Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

NCT03499808Phase 2Completed

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

NCT02514304CompletedPrimary

Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding

NCT07002359Active Not RecruitingPrimary

Assessment of Laboratory Parameters and Imaging Findings in Patients With Gastrointestinal Bleeding

NCT06877507Not Yet Recruiting

Rapid Diagnostic Technology for AUGIB Based on Analysis of VOCs in Exhaled Breath

NCT05816473Not ApplicableCompletedPrimary

Artificial Intelligent Clinical Decision Support System Simulation Center Study for Technology Acceptance

NCT06553105Not Yet Recruiting

Diagnosis and Clinical Presentation of Iliac Graft-Enteric Fistula: A Case Report

NCT06269588Not ApplicableUnknownPrimary

Efficacy and Safety of Nexpowder™ for Non-variceal, Upper Gastrointestinal Bleeding

NCT06269302Completed

Comparison of the Effect of Warfarin and Direct Oral Anticoagulants

NCT05226221Recruiting

Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality

NCT02384122Phase 3Completed

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias

NCT05353062Not ApplicableUnknownPrimary

Bipolar Hemostatic Forceps Versus Standard Therapy in Acute Non-variceal Upper GI Bleeding

NCT02928939CompletedPrimary

Therapeutic Conflicts and Multimorbidity

NCT04748081CompletedPrimary

The Major Bleeding Risk Following Hepatectomy

NCT02929563Phase 3CompletedPrimary

Pediatric Intensive Care Ulcer Prophylaxis Pilot Trial

NCT02820077Not ApplicableTerminatedPrimary

Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions

NCT04184934UnknownPrimary

Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal Hemorrhage

NCT03028064Completed

Point of Care Testing of Platelet Function in Patients With Acute Upper Gastrointestinal Bleeding

NCT04226079UnknownPrimary

Volatile Organic Compounds (VOCs) of Exhaled Breath in Patients With GI Bleeding

Scroll to load more

Research Network

Activity Timeline